SCHEMBL29914626

SCHEMBL29914626

O=C1c2cc(Br)ccc2-c2cc(Cl)ccc21

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ S100A4 P26447 4/20 0.63
▸ PTPRC P08575 1/20 0.60
▸ BCL2 P10415 3/20 0.58
▸ MCL1 Q07820 2/20 0.58
▸ HSP90AA1 P07900 1/20 0.49
▸ ITGA1 P56199 1/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ PPOX P50336 1/20 0.42
▸ ESR1 P03372 1/20 0.42
▸ MAOA P21397 1/20 0.42
▸ UGT1A1 P22309 1/20 0.42
▸ MAOB P27338 1/20 0.42
▸ ESR2 Q92731 1/20 0.42
▸ LCK P06239 1/20 0.41
▸ CA1 P00915 1/20 0.40
▸ CA2 P00918 1/20 0.40
▸ CA4 P22748 1/20 0.40
▸ CA7 P43166 1/20 0.40
▸ CA9 Q16790 1/20 0.40
▸ CYP1A2 P05177 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23294517 1.00 S100A4 (0.63) S100A4PTPRCBCL2MCL1HSP90AA1
SCHEMBL24730389 0.96 BCL2 (0.57) S100A4PTPRCBCL2MCL1HSP90AA1
SCHEMBL6884062 0.96 BCL2 (0.62) S100A4PTPRCBCL2MCL1HSP90AA1
SCHEMBL29018327 0.93 S100A4 (0.72) S100A4PTPRCBCL2MCL1HSP90AA1
SCHEMBL1758285 0.92 S100A4 (0.61) S100A4PTPRCBCL2MCL1HSP90AA1
SCHEMBL19767754 0.88 S100A4 (0.81) S100A4PTPRCBCL2MCL1ESR1
SCHEMBL16659000 0.83 S100A4 (0.90) S100A4PTPRCBCL2MCL1HSP90AA1
SCHEMBL4319897 0.83 S100A4 (0.71) S100A4HSP90AA1ITGA1PPOXESR1
SCHEMBL762135 0.83 S100A4 (0.80) S100A4PTPRCBCL2MCL1NPC1
SCHEMBL39700 0.83 S100A4 (0.90) S100A4PTPRCBCL2MCL1HSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4051667-A1 HETEROCYCLIC CARBOXYLATE COMPOUNDS AS GLYCOLATE OXIDASE INHIBITORS Lilac Therapeutics, Inc. (US) 2022-09-07 — — EP disclosed
Send feedback